Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;18(10):689-700.
doi: 10.1038/s41569-021-00541-4. Epub 2021 Apr 8.

Global epidemiology of dyslipidaemias

Angela Pirillo  1   2 , Manuela Casula  2   3 , Elena Olmastroni  3 , Giuseppe D Norata  1   4 , Alberico L Catapano  5   6
Affiliations
Review

Global epidemiology of dyslipidaemias

Angela Pirillo et al. Nat Rev Cardiol. 2021 Oct.

Abstract

Dyslipidaemias are alterations to the plasma lipid profile that are often associated with clinical conditions. Dyslipidaemias, particularly elevated plasma LDL-cholesterol levels, are major risk factors for cardiovascular disease, but some forms, such as hypertriglyceridaemia, are associated with severe diseases in other organ systems, including non-alcoholic fatty liver disease and acute pancreatitis. Dyslipidaemias can be genetically determined (primary or familial dyslipidaemias) or secondary to other conditions (such as diabetes mellitus, obesity or an unhealthy lifestyle), the latter being more common. Hypercholesterolaemia is the most common form of dyslipidaemia and is associated with an increased risk of cardiovascular disease, with elevated plasma LDL-cholesterol levels being the 15th leading risk factor for death in 1990, rising to 11th in 2007 and 8th in 2019. The global burden of dyslipidaemias has increased over the past 30 years. Furthermore, the combination of high triglyceride levels and low HDL-cholesterol levels (together with the presence of small, dense LDL particles), referred to as atherogenic dyslipidaemia, is highly prevalent in patients with diabetes or metabolic syndrome and increases their risk of cardiovascular disease. Given the increasing prevalence of diabetes worldwide, treating lipid abnormalities in these patients might reduce their risk of cardiovascular disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization. Noncommunicable diseases: risk factors. The Global Health Observatory https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/ncd-ri... (2021).
    1. Global Health Data Exchange. GBD results tool. Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/gbd-results-tool (2021).
    1. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1923–1994 (2018). - DOI
    1. NCD Risk Factor Collaboration (NCR-RisC). Repositioning of the global epicentre of non-optimal cholesterol. Nature 582, 73–77 (2020). - DOI
    1. Hulman, A. et al. Effect of secular trends on age-related trajectories of cardiovascular risk factors: the Whitehall II longitudinal study 1985–2009. Int. J. Epidemiol. 43, 866–877 (2014). - PubMed - PMC - DOI

Publication types

MeSH terms

LinkOut - more resources